Who is sponsoring MICH?

MICH is sponsored by Leiden University Medical Center.

What condition does MICH study?

MICH studies Kidney Transplantation, Immunity.

Last reviewed 2015-03-25 · How we verify

Immune Response After Inactivated Oral Cholera Vaccine (Dukoral) in Renal Transplant Recipients (MICH)

NCT01109914 Phase 4 COMPLETED

The aim of this study is to verify whether vaccination with Dukoral® (SBL Vaccines) induces an immune response in renal transplant recipients on prednisolone in combination with either a calcineurin inhibitor CNI) or mycophenolate mofetil (MMF).

Details

Lead sponsor	Leiden University Medical Center
Phase	Phase 4
Status	COMPLETED
Enrolment	51
Start date	2010-04
Completion	2015-03

Conditions

Kidney Transplantation
Immunity

Interventions

Dukoral

Primary outcomes

Percentage seroconversion among all renal transplant recipients. — day 20-22
≥3-fold rise in serum anti-CTB antibodies or ≥4-fold rise in serum vibriocidal antibodies.

Countries

Netherlands